Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort

Transplant International

Volumn 24, Issue 12, 2011, Pages 1231-1238

  Oetting, William S ^a,b   Schladt, David P ^b   Leduc, Robert E ^b   Jacobson, Pamala A ^a   Guan, Weihua ^b   Matas, Arthur J ^c   Israni, Ajay ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

acute rejection; genetic variation and validation; kidney transplantation; single nucleotide polymorphisms

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

ACUTE DISEASE; COHORT STUDIES; FACTOR V; GENETIC ASSOCIATION STUDIES; GRAFT REJECTION; HUMANS; IMP DEHYDROGENASE; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 80755144029     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01359.x     Document Type: Article

References (40)

1. Matas AJ, Gillingham KJ, Payne WD, Najarian JS,. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857.
2. Paraskevas S, Kandaswamy R, Humar A, et al. Risk factors for rising creatinine in renal allografts with 1 and 3 yr survival. Clin Transplant 2006; 20: 667.
3. Marder B, Schröppel B, Murphy B,. Genetic variability and transplantation. Curr Opin Urol 2008; 13: 81.
4. Goldfarb-Rumyantzev AS, Naiman N,. Genetic prediction of renal transplant outcome. Curr Opin Nephrol Hypertens 2008; 17: 573.
5. Krüger B, Schröppel B, Murphy BT,. Genetic polymorphisms and the fate of the transplanted organ. Transplant Rev (Orlando) 2008; 22: 131.
6. Nickerson P,. The impact of immune gene polymorphisms in kidney and liver transplantation. Clin Lab Med 2008; 28: 455.
7. Israni A, Leduc R, Holmes J, et al. Single nucleotide polymorphisms, acute rejection and severity of tubulitis in kidney transplantation. Transplantation 2010; 90: 1401.
8. Grinyõ J, Vanrenterghem Y, Nashan B, et al. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int 2008; 21: 879.
9. Zhang G, Wang H, Wang F, et al. Gene polymorphisms of the renin-angiotensin-aldosterone system and angiotensin II type 1-receptor activating antibodies in renal rejection. Tohoku J Exp Med 2007; 213: 203.
10. Quteineh L, Verstuyft C, Furlan V, et al. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients. Basic Clin Pharmacol Toxicol 2008; 103: 546.
11. Kang SW, Park SJ, Kim YW, et al. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients. Int J Immunogenet 2008; 35: 25.
12. Krüger B, Böger CA, Obed A, et al. RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection. Clin Transplant 2007; 21: 385.
13. Abdi R, Tran TB, Sahagun-Ruiz A, et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002; 13: 754.
14. Cha RH, Yang SH, Kim HS, et al. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5. Nephrol Dial Transplant 2009; 24: 2919.
15. Hocher B, Slowinski T, Hauser I, et al. Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients. Thromb Haemost 2002; 87: 194.
16. Yuan FF, Watson N, Sullivan JS, et al. Association of Fc gamma receptor IIA polymorphisms with acute renal-allograft rejection. Transplantation 2004; 78: 766.
17. Tajik N, Salari F, Ghods AJ, Hajilooi M, Radjabzadeh MF, Mousavi T,. Association between recipient ICAM-1 K469 allele and renal allograft acute rejection. Int J Immunogenet 2008; 35: 9.
18. Manchanda PK, Mittal RD,. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation. Mol Cell Biochem 2008; 311: 57.
19. Morgun A, Shulzhenko N, Rampim GF, et al. Interleukin-2 gene polymorphism is associated with renal but not cardiac transplant outcome. Transplant Proc 2003; 35: 1344.
20. Poole KL, Gibbs PJ, Evans PR, Sadek SA, Howell WM,. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transpl Immunol 2001; 8: 259.
21. Singh R, Kesarwani P, Ahirwar DK, Kapoor R, Mittal RD,. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India. Transpl Immunol 2009; 21: 13.
22. Alakulppi NS, Kyllönen LE, Jäntti VT, et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation 2004; 78: 1422.
23. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56: 281.
24. Kim CD, Ryu HM, Choi JY, et al. Association of G-137C IL-18 promoter polymorphism with acute allograft rejection in renal transplant recipients. Transplantation 2008; 86: 1610.
25. Wang J, Yang JW, Zeevi A, et al. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients. Clin Pharmacol Ther 2008; 83: 711.
26. Tinckam K, Rush D, Hutchinson I, et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 2005; 79: 836.
27. Salido E, Martín B, Barrios Y, et al. The PlA2 polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection. J Am Soc Nephrol 1999; 10: 2599.
28. Park JY, Park MH, Park H, Ha J, Kim SJ, Ahn C,. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans. Tissue Antigens 2004; 64: 660.
29. Ducloux D, Deschamps M, Yannaraki M, et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005; 67: 2454.
30. Hwang YH, Ro H, Choi I, et al. Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Transplantation 2009; 88: 699.
31. Pawlik A, Domanski L, Rozanski J, et al. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection. Transplant Proc 2005; 37: 2041.
32. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13: 260.
33. Yigit B, Bozkurt N, Berber I, Titiz I, Isbir T,. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival. Cell Biochem Funct 2007; 25: 423.
34. Van Ness B, Ramos C, Haznadar M, et al. Genomic variation in myeloma. design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Med 2008; 6: 26.
35. Hsieh H, Lavori PW,. Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates. Control Clin Trials 2000; 21: 552.
36. Bertina RM, Koelman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64.
37. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH,. High risk of thrombosis in patients homogygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504.
38. Ekberg H, Svensson PJ, Simanaitis M, Dahlbäck B,. Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. Transplantation 2000; 69: 1577.
39. Winnicki W, Weigel G, Sunder-Plassmann G, et al. An inosine 5â -monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid. Pharmacogenomics J 2010; 10: 70.
40. Mardis ER,. The $1,000 genome, the $100,000 analysis? Genome Med 2010; 2: 84.